HIV and HCV Intervention In Drug Treatment Settings - 1

This study has been completed.

Sponsor:

Collaborator:

Oregon Health and Science University

Information provided by:

National Institute on Drug Abuse (NIDA)

ClinicalTrials.gov Identifier:

NCT00102349

First received: January 27, 2005

Last updated: April 13, 2010

Last verified: April 2010

History of Changes

Purpose

The purpose of this study is to test two strategies to reduce the risk of contracting Human Immunodeficiency Virus (HIV) or Hepatitis C Virus (HCV) by reducing risk behaviors in patients undergoing drug detoxification.

Condition	Intervention	Phase
Behavior Therapy	Behavioral: Behavior Therapy	Phase 3


Study Type:	Interventional
Study Design:	Primary Purpose: Prevention
Official Title:	HIV and HCV Intervention in Drug Treatment Settings

Resource links provided by NLM:

MedlinePlus related topics: HIV/AIDS

U.S. FDA Resources

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:

HIV/HCV injection risk behaviors


Estimated Enrollment:	706
Study Start Date:	November 2004
Study Completion Date:	February 2006
Primary Completion Date:	February 2006 (Final data collection date for primary outcome measure)

Eligibility


Ages Eligible for Study:	18 Years and older (Adult, Senior)
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Volunteers will be IV drug users already enrolled in drug detoxification treatment.

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00102349

Locations


United States, Colorado
Denver Health & Hosp Authority
Denver, Colorado, United States, 80204 4507
Island Grove RTC
Greeley, Colorado, United States, 80631
United States, Massachusetts
SSTAR (Stanley St. Treatment & Resources, Inc)
Fall River, Massachusetts, United States, 02720
United States, Michigan
James Gilmore Jr. Treatment Center
Kalamazoo, Michigan, United States, 49408
United States, Oregon
Willamette Family Treatment Services
Eugene, Oregon, United States, 97402
United States, Rhode Island
SSTAR of Rhode Island - North Kingstown
North Kingstown, Rhode Island, United States, 02852
United States, Washington
Recovery Center King Co.-Kent Detox
Kent, Washington, United States, 98032
Recovery Center King Co.-Seattle Detox
Seattle, Washington, United States, 98144

Sponsors and Collaborators

University of Colorado, Denver

Oregon Health and Science University

Investigators


Principal Investigator:	Robert Booth, Ph.D.	University of Colorado, Denver

More Information


Responsible Party:	Robert Booth, Ph.D., University of Colorado at Denver
ClinicalTrials.gov Identifier:	NCT00102349 History of Changes
Other Study ID Numbers:	NIDA-CTN-0017-1
Study First Received:	January 27, 2005
Last Updated:	April 13, 2010
Health Authority:	United States: Federal Government

ClinicalTrials.gov processed this record on September 30, 2016

To Top